Drs. Jeremy Kortmansky and Sajid Khan explain the Hepatic Arterial Infusion (HAI) Program at Smilow Cancer Hospital and Yale Cancer Center.
The Hepatic Arterial Infusion (HAI) Program at Smilow Cancer Hospital consists of a multidisciplinary team of nationally recognized physicians who are experts in diagnosing, treating, and providing care for patients with colorectal cancer, cholangiocarcinoma (bile duct cancer), and liver cancer.
HAI is a specialized and targeted approach to deliver chemotherapy directly to the liver, primarily used in the treatment of advanced liver metastases from colorectal cancer, in addition to intrahepatic cholangiocarcinoma. Traditional systemic chemotherapy and immunotherapy may not provide enough concentration of the drug within the liver while minimizing exposure to the rest of the body.
For information or referrals, please call 203-407-8002 (GI Medical Oncology) or 203-337-8507 (Surgical Oncology).